Related Experiment Video

Updated: Apr 18, 2026

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

9.6K

Highlights from the latest research in nanomedicine

Sophie L Wang1, Upendra Chitgupi, Jonathan F Lovell

  • 1Department of Biomedical Engineering, University at Buffalo, State University of New York, Buffalo, NY 14260, USA.

Nanomedicine (London, England)
|January 20, 2015
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
07:54

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

8.8K
Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy
08:09

Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy

Published on: April 6, 2015

12.3K

Related Experiment Videos

Last Updated: Apr 18, 2026

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

9.6K
Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
07:54

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

8.8K
Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy
08:09

Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy

Published on: April 6, 2015

12.3K

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.4K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
1.8K

Articles linked to this work by shared authors, journal, and citation graph.

Manganese Capture-and-Release Vesicles for Cancer Immunotherapy.

Advanced materials (Deerfield Beach, Fla.)·2026

Engineering internally his-tagged ESX secretion system fusion antigens for tuberculosis nanoparticle vaccines.

The Journal of biological chemistry·2026

Single-cell profiling of gastric cancer ascites reveals an epithelial-immune dual phenotype signature predictive for anti-PD-1 immunotherapy responses.

BMC medicine·2026

A subunit vaccine for multiple respiratory viruses.

Science advances·2026

Immunogenicity of Theileria parva p67C Antigen Delivered via Adjuvanted CoPoP Liposomes in Cattle and Mice.

Vaccines·2026

Engineered metallo-albumin nanoscaffolds that target lymph nodes, deliver antigens and activate STING for cancer immunotherapy.

Biomaterials·2026

Ultrasound-responsive microencapsulated curcumin nanobubbles for treatment of mice rheumatoid arthritis and mechanistic insights based on single-cell Transcriptomics.

Nanomedicine (London, England)·2026

The protection of chitosan-coated triptolide-magnesium nanoparticles against intervertebral disc degeneration via MAPK signaling and mitophagy.

Nanomedicine (London, England)·2026

Astragaloside IV and rapamycin co-loaded bone marrow mesenchymal stem cell-derived exosome nanocarriers for targeted modulation of the PI3K/Akt/mTOR pathway in hepatocellular carcinoma.

Nanomedicine (London, England)·2026

Glutathione-responsive gambogic acid-conjugated carboxymethyl chitosan/graphene quantum dot nanoparticles for chemo-photothermal-photodynamic synergistic therapy of drug-resistant breast cancer.

Nanomedicine (London, England)·2026

Nanoparticles for fluorescence-guided breast cancer surgery: advances in in vivo preclinical research.

Nanomedicine (London, England)·2026

Cationic lipid-based targeted nanocarriers for respiratory diseases in children: prospects and challenges.

Nanomedicine (London, England)·2026

Pathogen-Mimetic Liposomes Customizing Protein Corona for Precision Glioblastoma Therapy.

Advanced materials (Deerfield Beach, Fla.)·2026

Breast Cancer Therapy with Quantum Dots: NIR-II Image-Guided Interventions, Multimodal Treatment, and Translation.

Current medicinal chemistry·2026

Echocardiographic characteristics of new-onset methamphetamine-associated heart failure: a retrospective cohort study.

Echo research and practice·2026

Nanoparticles-mediated dual drug administration boosts therapeutic efficacy in drug resistant melanoma.

Journal of controlled release : official journal of the Controlled Release Society·2026

Advances in non-invasive brain stimulation for borderline personality disorder: clinical targets and future directions - an updated narrative review.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry·2026

Advances in metal-organic frameworks (MOFs) for nanotheranostics: from targeted drug delivery to multimodal imaging.

Mikrochimica acta·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us